Company
Headquarters: Shenzhen, China
Employees: 1,949
CN¥47.96 Billion
CNY as of July 1, 2024
US$6.60 Billion
Company | Market Cap (USD) |
---|---|
Abbott | $178.02 B |
Stryker Corporation | $126.48 B |
Boston Scientific Corporation | $112.32 B |
Medtronic | $98.95 B |
Edwards Lifesciences Corporation | $55.63 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Shenzhen New Industries Biomedical Engineering Co., Ltd., a bio-medical company, engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals and laboratories in China and internationally. It offers immunology, clinical chemistry, and integrated systems, as well as immunoassay and clinical chemistry reagent kits. The company was founded in 1995 and is based in Shenzhen, China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Shenzhen New Industries Biomedical Engineering Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300832 wb_incandescent